News

Mary Lisbeth D'Amico's first fortnightly funding column reveals how coming out on top in a start-up talent show does not guarantee funding.

Oslo-based anticancer company Algeta has closed a series A financing round totaling €23 million.

Nemerix, a semiconductor company spun out from the Swiss Federal Institute of Technology in Zurich, has closed a €25 million series B financing round.

A new life-science fund said it raised €240.3 million – and promptly announced its first two investments.

Europe looks increasingly likely to follow America’s lead and require drug companies to test their products in children. But Europe's pharma lack the resources to carry out drug trials in children — so industry and patients will have to rely on the skills developed in academic centres.

Avidex is teaming up with diabetes specialists at King’s College London to work on a new approach to treating the Type I form of the disease.